MENU
+Compare
CYBN
Stock ticker: ASE
AS OF
Jul 21, 12:39 PM (EDT)
Price
$8.12
Change
-$0.21 (-2.52%)
Capitalization
190.29M

CYBN Cybin Inc Forecast, Technical & Fundamental Analysis

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues... Show more

CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CYBN with price predictions
Jul 18, 2025

CYBN in -2.36% downward trend, declining for three consecutive days on July 15, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CYBN declined for three days, in of 352 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for CYBN crossed bearishly below the 50-day moving average on July 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where CYBN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 17, 2025. You may want to consider a long position or call options on CYBN as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CYBN just turned positive on July 18, 2025. Looking at past instances where CYBN's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

CYBN moved above its 50-day moving average on July 17, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CYBN advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 113 cases where CYBN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.106) is normal, around the industry mean (18.143). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). CYBN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (270.975).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CYBN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYBN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CYBN is expected to report earnings to fall 98.30% to -2 cents per share on November 13

Cybin Inc CYBN Stock Earnings Reports
Q3'24
Est.
$-0.02
Q1'25
Missed
by $1.44
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.03
Q4'23
Missed
by $0.03
The last earnings report on July 01 showed earnings per share of -146 cents, missing the estimate of -2 cents. With 201.70K shares outstanding, the current market capitalization sits at 190.29M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 King Street West
Phone
+1 908 764-8385
Employees
50
Web
https://www.cybin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACNFF26.32N/A
N/A
Amsterdam Commodities N.V.
TCMFF1.25N/A
N/A
Telecom Argentina S.A.
RIOCF12.94-0.12
-0.93%
Riocan Real Estate Investment Trust
ELTP0.56-0.01
-1.57%
Elite Pharmaceuticals, Inc.
EPOAY20.77-2.03
-8.90%
Epiroc Aktiebolag

CYBN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
-1.65%
ATAI - CYBN
43%
Loosely correlated
+15.77%
RXRX - CYBN
37%
Loosely correlated
+5.80%
ABSI - CYBN
36%
Loosely correlated
+8.33%
EYPT - CYBN
31%
Poorly correlated
N/A
ABCL - CYBN
30%
Poorly correlated
+14.62%
More